169 related articles for article (PubMed ID: 7505737)
21. [Clinical significance of determination of urinary albumin, beta 2 microglobulin and Tamm-Horsfall protein in diabetics].
Yu M; Zhu YQ
Zhonghua Nei Ke Za Zhi; 1991 Jun; 30(6):354-6, 383. PubMed ID: 1914672
[TBL] [Abstract][Full Text] [Related]
22. Reduction of urinary albumin excretion by thromboxane synthetase inhibitor, OKY-046, through modulating renal prostaglandins in patients with diabetic nephropathy.
Tajiri Y; Inoguchi T; Umeda F; Nawata H
Diabetes Res Clin Pract; 1990; 10(3):231-9. PubMed ID: 2073870
[TBL] [Abstract][Full Text] [Related]
23. Transcapillary escape rate of albumin in hypertensive patients with type 1 (insulin-dependent) diabetes mellitus.
Nørgaard K; Jensen T; Feldt-Rasmussen B
Diabetologia; 1993 Jan; 36(1):57-61. PubMed ID: 8436254
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme inhibitors and probucol suppress the time-dependent increase in urinary Type IV collagen excretion of Type II diabetes mellitus patients with early diabetic nephropathy.
Nishimura M; Sasaki T; Ohishi A; Oishi M; Kono S; Totani Y; Kato Y; Noto Y; Misaki S; Higashi K; Shimada F; Wakasugi H; Inoue K; Hoshiyama Y; Yamada K
Clin Nephrol; 2001 Aug; 56(2):96-103. PubMed ID: 11522101
[TBL] [Abstract][Full Text] [Related]
25. Increased collagen IV excretion in diabetes. A marker of compromised filtration function.
Cohen MP; Lautenslager GT; Shearman CW
Diabetes Care; 2001 May; 24(5):914-8. PubMed ID: 11347754
[TBL] [Abstract][Full Text] [Related]
26. Contrasting effects of angiotensin converting inhibitor and alpha-1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy.
Holdaas H; Hartmann A; Berg KJ; Langberg H; Blystad L; Fauchald P
J Intern Med; 1995 Jan; 237(1):63-71. PubMed ID: 7830033
[TBL] [Abstract][Full Text] [Related]
27. Proximal tubular reabsorption of growth hormone and sodium/fluid in normo- and microalbuminuric insulin-dependent diabetes mellitus.
Turner G; Coates P; Warren S; Woodhead JS; Peters JR
Acta Diabetol; 1997 Mar; 34(1):27-32. PubMed ID: 9134054
[TBL] [Abstract][Full Text] [Related]
28. The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study.
Kawazu S; Tomono S; Shimizu M; Kato N; Ohno T; Ishii C; Murata K; Watanabe T; Negishi K; Suzuki M
J Diabetes Complications; 1994; 8(1):13-7. PubMed ID: 8167381
[TBL] [Abstract][Full Text] [Related]
29. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
[TBL] [Abstract][Full Text] [Related]
30. Increased urinary endothelin-1-like immunoreactivity excretion in NIDDM patients with albuminuria.
Lee YJ; Shin SJ; Tsai JH
Diabetes Care; 1994 Apr; 17(4):263-6. PubMed ID: 8026280
[TBL] [Abstract][Full Text] [Related]
31. Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin.
Nielsen S; Schmitz A; Bacher T; Rehling M; Ingerslev J; Mogensen CE
Diabetologia; 1999 Jan; 42(1):60-7. PubMed ID: 10027580
[TBL] [Abstract][Full Text] [Related]
32. Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
Skrha J; Perusicová J; Pont'uch P; Oksa A
Diabetes Res Clin Pract; 1997 Oct; 38(1):25-31. PubMed ID: 9347243
[TBL] [Abstract][Full Text] [Related]
33. Effect of metabolic control and duration on exercise-induced albuminuria in diabetic teen-agers.
Dahlquist G; Aperia A; Carlsson L; Linné T; Persson B; Thorén C; Wilton P
Acta Paediatr Scand; 1983 Nov; 72(6):895-902. PubMed ID: 6369869
[TBL] [Abstract][Full Text] [Related]
34. [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation].
Jungmann E; Carlberg C; Schallmayer M; Schumm-Draeger PM
Med Klin (Munich); 1995 Jul; 90(7):383-9. PubMed ID: 7675002
[TBL] [Abstract][Full Text] [Related]
35. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
Banu N; Hara H; Okamura M; Egusa G; Yamakido M
Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
[TBL] [Abstract][Full Text] [Related]
36. Urinary excretion of angiotensin-converting enzyme in NIDDM patients with nephropathy.
Hosojima H; Miyauchi E; Morimoto S
Diabetes Care; 1989 Sep; 12(8):580-2. PubMed ID: 2550187
[TBL] [Abstract][Full Text] [Related]
37. Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus.
Wiseman M; Viberti G; Mackintosh D; Jarrett RJ; Keen H
Diabetologia; 1984 Jun; 26(6):401-5. PubMed ID: 6468790
[TBL] [Abstract][Full Text] [Related]
38. Microproteinuria in type 2 diabetes mellitus from diagnosis.
Martin P; Hampton KK; Walton C; Tindall H; Davies JA
Diabet Med; 1990 May; 7(4):315-8. PubMed ID: 1692521
[TBL] [Abstract][Full Text] [Related]
39. Triphasic changes in selectivity with increasing proteinuria in type 1 and type 2 diabetes.
Jerums G; Allen TJ; Cooper ME
Diabet Med; 1989 Dec; 6(9):772-9. PubMed ID: 2533035
[TBL] [Abstract][Full Text] [Related]
40. Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy.
Gilbert RE; Akdeniz A; Weitz S; Usinger WR; Molineaux C; Jones SE; Langham RG; Jerums G
Diabetes Care; 2003 Sep; 26(9):2632-6. PubMed ID: 12941731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
